Using inhaled corticosteroids as the mainstay of asthma therapy

T. K. Horiuchi, M. Castro

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Inhaled corticosteroids (ICs) are the most effective anti-inflammatory agents available for the treatment of asthma. Since proper inhalation technique can significantly affect the amount of ICs delivered via metered-dose inhaler (MDI) or dry powder inhaler to the airways, patient education is essential. Large-volume spacer devices used with MDIs may double the efficacy of ICs by enhancing lung deposition, possibly reducing dosage and cost of therapy. At currently recommended dosages, ICs have an excellent safety profile and should be considered the mainstay of asthma therapy.

Original languageEnglish
Pages (from-to)358-368
Number of pages11
JournalJournal of Respiratory Diseases
Issue number6
StatePublished - Jan 1 2001


Dive into the research topics of 'Using inhaled corticosteroids as the mainstay of asthma therapy'. Together they form a unique fingerprint.

Cite this